News

At the NAMI New York State Education Conference held on November 11-12 in Albany, two NKI researchers were presented with awards. Matthew Hoptman, PhD, received the 2022 Excellence in Research Award, recognizing his decades of work studying impulsivity and aggression and his recent work on suicidality in schizophrenia employing a variety of neuroimaging modalities. Dr. … NAMI-NYS Awards Recognize Two NKI Investigators

Ayana Jordan, MD, PhD, has been selected by the American Society of Addiction Medicine (ASAM) to be the first recipient of ASAM’s Award for the Promotion of Inclusion, Diversity, Equality and Justice in Addiction Medicine. This award recognizes and honors an individual whose work in the area of injustice related to addiction care has improved … Dr. Ayana Jordan Receives the First ASAM DEI Award

A new paper published in Nature Protocols by Pasquale D’Acunzo, Yohan Kim, Jonathan M. Ungania, Rocío Pérez-González, Chris N. Goulbourne, and Efrat Levy, all current or former members of the Center for Dementia Research (CDR), describes in great detail a method to isolate, fractionate, and analyze subpopulations of extracellular vesicles from the extracellular space of the … The Levy Laboratory Describes a Method to Isolate a Novel Type of Extracellular Vesicle from the Brain

Ralph A. Nixon, Ph.D., M.D., Director of NKI’s Center for Dementia Research, has spent the last three decades working to uncover the fundamental cellular basis of Alzheimer’s disease. This work by Dr. Nixon and his laboratory has been recognized with the awarding of the Oskar Fischer Prize, an international competition to expand society’s understanding of … Dr. Ralph Nixon Receives Oskar Fischer Gold Prize

A new open access paper in Nature Neuroscience by Ju-Hyun Lee, PhD, Center for Dementia Research (CDR) Director Ralph Nixon, MD, PhD, and colleagues presents the latest evidence from the Nixon Lab challenging the prevailing theory of how Alzheimer’s disease originates.  Rather, this research suggests that Alzheimer’s disease develops due to lysosomal dysfunction within cells, … Nixon Lab Provides Further Evidence for Alternative Alzheimer’s Theory

Crystal Lewis, PhD, Director of the Social Solutions & Services Division at NKI, received the NYU Department of Psychiatry’s “Research Mentorship of Faculty Award” in recognition of her exceptional mentorship and career development contributions. Dr. Lewis’s nominations for this award highlighted her work in social justice as informing her mentoring, and her impact through her … Dr. Crystal Lewis Receives Faculty Mentorship Award

Dan Iosifescu, MD, Professor of Psychiatry at New York University School of Medicine and Director of Clinical Research at NKI, is the senior author of a new paper reporting promising results for an experimental treatment for major depressive dirsorder. The publication is a collaboration with Axsome Therapeutics and appears in The American Journal of Psychiatry. In … New Depression Treatment Shows Promise

Dr. Ralph Nixon, Director of the Center for Dementia Research, has been selected by New Vision Research as the first recipient of The Leonard Litwin Scholar Award that was introduced in 2021 as a means of supporting scientists who have demonstrated commitment to the advancement of research in Alzheimer’s disease (AD). The award, funded through New … Dr. Ralph Nixon Receives The Leonard Litwin Scholar Award

Two NKI investigators have once again been recognized for their high-impact research. Drs. F. Xavier Castellanos and Michael P. Milham both appear on the 2021 list of Highly Cited Researchers compiled by Clarivate. Both have made the list every year since 2014, demonstrating their consistent output and influence. The Highly Cited Researchers list recognizes the world’s most … NKI Researchers Are Consistently Among the Most Highly Cited